Clin2
NCT07619833Worth exploringNot yet recruiting

Combination therapy for type 2 diabetes control

T2DM (Type 2 Diabetes Mellitus)

Treatments studied

Part of Hormones & metabolism clinical trials.

This study combines two different diabetes medications (called DWP16001 and DWC202518) to see if starting them together works better than either one alone for lowering blood sugar. It is for adults with type 2 diabetes who need better control and have not yet tried or have only taken one diabetes pill.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
510 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Adults aged 18 to 80 years (19+ in South Korea)
  • Diagnosed with type 2 diabetes
  • Either new to diabetes pills (no pills in the last 12 weeks) or currently on just one pill
  • A1c blood sugar level must be between 7.5% and 11% at screening
  • Fasting blood sugar below 270 mg/dL
  • Body mass index (BMI) between 20 and 45 kg/m²

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07441187Not yet recruiting
New triple tablet for type 2 diabetes

This trial tests a new combination pill that includes three medications to lower blood sugar in people with type 2 diabetes. It aims to see if this combination is safe and effective for Chinese patients.

NCT07034781Not yet recruiting· Phase 1
Study of a combination diabetes pill in healthy adults

This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.

Gwangmyeong, Gyeonggi-do
NCT06606093Not yet recruiting· Phase 3
Study of a new medicine for type 2 diabetes with moderate kidney problems

This trial tests a new oral medication (DWP16001) for people with type 2 diabetes who also have moderate kidney problems. It aims to see if the drug is safe and helps control blood sugar while protecting kidney function.

Ansan, Gyeongggi-do
NCT06772168Recruiting· Phase 3
New combo pill for diabetes and high cholesterol

This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.

Anyang
NCT07365358Not yet recruiting· Phase 4
Combination diabetes pills for type 2 diabetes

This trial tests two diabetes medications—empagliflozin and glimepiride—used together to see if the combination works better and is safe for people with type 2 diabetes. If you're already on diabetes pills, this could help improve your blood sugar control.

Seoul
NCT07552389Recruiting· Phase 3
Blood Pressure and Diabetes Combination Drug Trial

This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.

Seoul

Hear when a new T2DM (Type 2 Diabetes Mellitus) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.